ATIII is a member of the serpin superfamily of serine protease inhibitors. ATIII, produced in the liver, is the prinicipal plasma serpin of blood clotting proteases, and inhibits thrombin, Factor Xa, as well as several other enzymes of the coagulation system. A deficiency or functional abnormality of ATIII may result in an increased risk of thromboembolic disease. ATIII also influences the inflammatory process.
Swiss-Prot Accession Number: P01008
A leading global drug discovery and development laboratory, IQVIA Laboratories (the laboratory business of IQVIA) provides customers with a comprehensive assemblage of solutions encompassing central laboratory and specialty biomarker services including genomics, immunoassays, flow cytometry, anatomic pathology, precision medicine assays, vaccine assays, ADME and bioanalytical along with extensive offerings in antibody drug discovery, biomarker discovery, and decentralized clinical trial lab solutions.
Learn more at labs.iqvia.com
Copyright 2025 Rules-Based Medicine. All rights reserved. RBM does not sell your personal information.